Gene · 6607
Papers3,510
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,421 to 1,440 of 3,510
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Risdiplam treatment has not led to retinal toxicity in patients with spinal muscular atrophy. | Ann Clin Transl Neurol | 2021 | 33231373 | PubTator, text mining | PubMed |
| Functional Abnormalities of Cerebellum and Motor Cortex in Spinal Muscular Atrophy Mice. | Neuroscience | 2021 | 33212215 | PubTator, text mining | PubMed |
| Characterization of Reference Materials for Spinal Muscular Atrophy Genetic Testing: A Genetic Testing Reference Materials Coordination Program Collaborative Project. | J Mol Diagn | 2021 | 33197628 | PubTator, text mining | PubMed |
| Early experiences of nusinersen for the treatment of spinal muscular atrophy: Results from a large survey of patients and caregivers. | Muscle Nerve | 2021 | 33184859 | PubTator, text mining | PubMed |
| Current and emerging therapies for Duchenne muscular dystrophy and spinal muscular atrophy. | Pharmacol Ther | 2021 | 33130193 | PubTator, text mining | PubMed |
| Real-world respiratory and bulbar comorbidities of SMA type 1 children treated with nusinersen: 2-Year single centre Australian experience. | Paediatr Respir Rev | 2021 | 33129670 | PubTator, text mining | PubMed |
| The Cure SMA Membership Surveys: Highlights of Key Demographic and Clinical Characteristics of Individuals with Spinal Muscular Atrophy. | J Neuromuscul Dis | 2021 | 33104036 | PubTator, text mining | PubMed |
| Clinical and radiological profile of patients with spinal muscular atrophy type 4. | Eur J Neurol | 2021 | 33090613 | PubTator, text mining | PubMed |
| Beyond the Traditional Clinical Trials for Amyotrophic Lateral Sclerosis and The Future Impact of Gene Therapy. | J Neuromuscul Dis | 2021 | 33074186 | PubTator, text mining | PubMed |
| Respiratory Trajectories in Type 2 and 3 Spinal Muscular Atrophy in the iSMAC Cohort Study. | Neurology | 2021 | 33067401 | PubTator, text mining | PubMed |
| Newborn Screening for Spinal Muscular Atrophy: Ontario Testing and Follow-up Recommendations. | Can J Neurol Sci | 2021 | 33059774 | PubTator, text mining | PubMed |
| A Novel Duplication in ATXN2 as Modifier for Spinocerebellar Ataxia 3 (SCA3) and C9ORF72-ALS. | Mov Disord | 2021 | 33058338 | PubTator, text mining | PubMed |
| Clinical phenotypes of spinal muscular atrophy patients with hybrid SMN gene. | Brain Dev | 2021 | 33036822 | PubTator, text mining | PubMed |
| Antisense Drugs Make Sense for Neurological Diseases. | Annu Rev Pharmacol Toxicol | 2021 | 33035446 | PubTator, text mining | PubMed |
| CMAP changes upon symptom onset and during treatment in spinal muscular atrophy patients: lessons learned from newborn screening. | Genet Med | 2021 | 33033402 | PubTator, text mining | PubMed |
| An observational cohort study on impact, dimensions and outcome of perceived fatigue in adult 5q-spinal muscular atrophy patients receiving nusinersen treatment. | J Neurol | 2021 | 33029682 | PubTator, text mining | PubMed |
| Heterogeneous Nuclear Ribonucleoproteins: Implications in Neurological Diseases. | Mol Neurobiol | 2021 | 33000450 | PubTator, text mining | PubMed |
| locStra: Fast analysis of regional/global stratification in whole-genome sequencing studies. | Genet Epidemiol | 2021 | 32929743 | PubTator, text mining | PubMed |
| NGS-based spinal muscular atrophy carrier screening of 10,585 diverse couples in China: a pan-ethnic study. | Eur J Hum Genet | 2021 | 32884118 | PubTator, text mining | PubMed |
| Natural history in spinal muscular atrophy Type I in Taiwanese population: A longitudinal study. | Brain Dev | 2021 | 32878721 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6607/papers?page=72